Th e GINECO trial explored the combination of trastuzumab with paclitaxel and carboplatin in patients with resistant AOC (< 6 months) and HER2 gene amplification. Patients and Methods: A total of ...

HER2-overexpressing breast cancer Trastuzumab, in combination with an anthracycline- and taxane-containing chemotherapy regimen, has become the universally-accepted standard of care for high-risk ...

After chemotherapy failure, if the cancer is also resistant to endocrine therapy, patients face a double obstacle: few ...

Pooled Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone in Patients With Advanced Melanoma In the article accompanying this editorial, Jensen et al 20 provide an update on the READ ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. 1. Why am I using Herceptin SC? Herceptin SC contains the active ...

A combination of tucatinib, trastuzumab and chemotherapy drug capecitabine is already approved for patients who have metastatic breast cancer with high levels of HER2 expression (known as HER2 ...

It’s often used alone or with other cancer treatments, including chemotherapy. Trastuzumab (Herceptin) and pertuzumab (Perjeta) are the two most common monoclonal antibodies used to treat human ...

Drugs used with chemotherapy Herceptin: Women with aggressive forms of breast cancer are being given new hope of survival with this drug. Although the drug is licensed in Britain, the drug has yet ...

Initial Clinical Data from Phase 1 Autoimmunity Study of FT819 1XX CAR T-cell Product Candidate to be Presented in 4Q24; Second Treatment Arm ...